Your account is not claimed yet. You can sign up with ORCID to claim your account.

Larissa Valor-Méndez (L Valor-Mendez, Larissa Valor Méndez)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 22

Top Venues

RMD open

Arthritis & rheumatology (Hoboken, N.J.)

Rheumatology advances in practice

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

M Weiss, Marie-Therese Holzer, Muehlensiepen Felix, Yuriy Ignatyev, Christoph Fiehn, J Bauhammer, Jens Schmidt, S Schlüter, A Dihkan, D Scheibner, Udo Schneider, Larissa Valor-Méndez, G Corte, Latika Gupta, Gabriela Arredondo Hector Chinoy, Ingrid E Lundberg, Lorenzo Cavagna, Jörg H W Distler, Larissa Valor-Méndez, Johannes Knitza
Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey. Rheumatology international (2023)
Larissa Valor-Méndez, Armin Atzinger, Petra Reis, Bernhard Manger, Larissa Valor-Méndez
Depiction of increased bone metabolism in secondary hyperparathyroidism. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
David Simon, Ioanna Minopoulou, Stephan Kemenes, Sara Bayat, Koray Tascilar, Melek Yalcin Mutlu, Larissa Valor-Méndez, Gerhard Krönke, Axel J Hueber, Larissa Valor-Méndez, Arnd Kleyer
Baricitinib improves bone properties and biomechanics in patients with rheumatoid arthritis - results of the prospective interventional BARE BONE trial. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Larissa Valor-Méndez, Armin Atzinger, Petra Reis, Bernhard Manger, Larissa Valor-Méndez
Depiction of increased bone metabolism in secondary hyperparathyroidism. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Larissa Valor-Méndez, Bernhard Manger, Martin Winterholler, Georg Schett, Mattias Türk, Johannes Knitza
Rare meets rarer: anti-synthetase syndrome in a patient with facio-scapulo-humeral muscular dystrophy. Rheumatology (Oxford, England) 61 (12) (2022)
Larissa Valor-Méndez, Bernhard Manger, Jochen Wacker, Arnd Kleyer, Georg Schett
Lymph node and pulmonary tuberculosis during upadacitinib treatment in a psoriatic arthritis patient. Rheumatology advances in practice 6 (2) (2022)
Filippo Fagni, Katja Schmidt, Daniela Bohr, Larissa Valor-Méndez, Fabian Hartmann, Koray Tascilar, Karin Manger, Bernhard Manger, Arnd Kleyer, David Simon, Georg Schett, Thomas Harrer
Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination. RMD open 8 (1) (2022)
Gwenda Simons, Jorien Veldwijk, Rachael L Disantostefano, Matthias Englbrecht, Christine Radawski, Karin Schölin Bywall, Larissa Valor-Méndez, Brett Hauber, Karim Raza, Marie Falahee
Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania. Rheumatology (Oxford, England) (2022)
Larissa Valor-Méndez, Bernhard Manger, Johannes Knitza, Christian Schmidkonz, Arnd Kleyer, Larissa Valor-Méndez
Clinical Images: Tissue remodeling in autoimmune statin-induced necrotizing autoimmune myopathy. ACR open rheumatology 4 (10) (2022)
Larissa Valor-Méndez, Carla Dorn, Bernhard Manger, Georg Schett, Arnd Kleyer
Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator. Rheumatology advances in practice 6 (3) (2022)
Larissa Valor-Méndez, Jochen Wacker, Larissa Valor-Méndez, Bernhard Manger, Julia Fürst, Richard Strauß, Arnd Kleyer
Clinical Images: Voriconazole-induced synovitis, enthesitis, and periostitis. Arthritis & rheumatology (Hoboken, N.J.) 74 (7) (2022)
Larissa Valor-Méndez, Bernhard Manger, Georg Schett, Arnd Kleyer
[Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib]. Zeitschrift fur Rheumatologie 80 (10) (2021)
Larissa Valor-Méndez, Bernhard Manger, Alexander Cavallaro, Stephan Achenbach, Georg Schett, Jürgen Rech
Autoinflammation leading to autoimmunity in adult-onset Still's disease: more than simple coincidence? European journal of medical research 26 (1) (2021)
Larissa Valor-Méndez, Koray Tascilar, David Simon, Joerg Distler, Arnd Kleyer, Larissa Valor-Méndez, Juergen Rech
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'. Annals of the rheumatic diseases 80 (10) (2021)

Larissa Valor-Méndez.css-eqlu8i{font-size:small;padding-left:4px;} (L Valor-Mendez, Larissa Valor Méndez)

Publication Activity (10 Years)

Top Topics

Top Venues

Larissa Valor-Méndez (L Valor-Mendez, Larissa Valor Méndez)